The impact of TCR-binding properties and antigen presentation format on T cell responsiveness

Journal of Immunology

Volumn 183, Issue 2, 2009, Pages 1166-1178

  Chervin, Adam S ^a   Stone, Jennifer D ^a   Holler, Phillip D ^a,b   Bai, Ailin ^b   Chen, Jianzhu ^b   Eisen, Herman N ^b   Kranz, David M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2; OLIGOMER; T LYMPHOCYTE RECEPTOR; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE RELEASE; GENE SWITCHING; HYBRIDOMA; IMMOBILIZED CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; T LYMPHOCYTE; ANIMAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMISTRY; IMMUNOLOGY; PROTEIN BINDING; SYNTHESIS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HYBRIDOMAS; LIGANDS; MICE; PEPTIDES; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; SURFACE PLASMON RESONANCE; T-LYMPHOCYTES;

EID: 70249091519     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900054     Document Type: Article

References (75)

1. Davis, M. M., J. J. Boniface, Z. Reich, D. Lyons, J. Hampl, B. Arden, and Y. Chien. 1998. Ligand recognition by αβT cell receptors. Annu. Rev. Immunol. 16: 523-544.
2. Eisen, H. N., Y. Sykulev, and T. J. Tsomides. 1996. Antigen-specific T-cell receptors and their reactions with complexes formed by peptides with major histocompatibility complex proteins. Adv. Protein Chem. 49: 1-56.
3. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24: 419-466.
4. Shimizu, T., Y. Kozono, H. Kozono, M. Oda, and T. Azuma. 2004. Affinity maturation of secreted IgM pentamers on B cells. Int. Immunol. 16: 675-684.
5. Anikeeva, N., T. Lebedeva, A. R. Clapp, E. R. Goldman, M. L. Dustin, H. Mattoussi, and Y. Sykulev. 2006. Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response. Proc. Natl. Acad. Sci. USA 103: 16846-16851.
6. - T cells that express the same antigen-specific receptor. Proc. Natl. Acad. Sci. USA 98: 1723-1727.
7. Daniels, M. A., and S. C. Jameson. 2000. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191: 335-346.
8. Wyer, J. R., B. E. Willcox, G. F. Gao, U. C. Gerth, S. J. Davis, J. I. Bell, P. A. van der Merwe, and B. K. Jakobsen. 1999. T cell receptor and coreceptor CD8 αα bind peptide-MHC independently and with distinct kinetics. Immunity 10: 219-225.
9. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart, J. I. Bell, E. Y. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex between human CD8αα and HLA-A2. Nature 387: 630-634.
10. Kern, P. S., M. K. Teng, A. Smolyar, J. H. Liu, J. Liu, R. E. Hussey, R. Spoerl, H. C. Chang, E. L. Reinherz, and J. H. Wang. 1998. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8αα ectodomain fragment in complex with H-2Kb. Immunity 9: 519-530.
11. Wooldridge, L., H. A. van den Berg, M. Glick, E. Gostick, B. Laugel, S. L. Hutchinson, A. Milicic, J. M. Brenchley, D. C. Douek, D. A. Price, and A. K. Sewell. 2005. Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface. J. Biol. Chem. 280: 27491-27501.
12. Davis, S. J., and P. A. van der Merwe. 2003. TCR triggering: co-receptor-dependent or -independent? Trends Immunol. 24: 624-626; author reply 626-627.
13. Purbhoo, M. A., D. J. Irvine, J. B. Huppa, and M. M. Davis. 2004. T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 5: 524-530.
14. Laugel, B., D. A. Price, A. Milicic, and A. K. Sewell. 2007. CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions. Eur. J. Immunol. 37: 905-913.
15. Laugel, B., H. A. van den Berg, E. Gostick, D. K. Cole, L. Wooldridge, J. Boulter, A. Milicic, D. A. Price, and A. K. Sewell. 2007. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 282: 23799-23810.
16. Yachi, P. P., J. Ampudia, T. Zal, and N. R. Gascoigne. 2006. Altered peptide ligands induce delayed CD8-T cell receptor interaction: a role for CD8 in distinguishing antigen quality. Immunity 25: 203-211.
17. Holler, P. D., and D. M. Kranz. 2003. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18: 255-264.
18. + cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 92: 11990-11992.
19. + T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate. J. Immunol. 179: 2952-2960.
20. Kalergis, A. M., N. Boucheron, M. A. Doucey, E. Palmieri, E. C. Goyarts, Z. Vegh, I. F. Luescher, and S. G. Nathenson. 2001. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat. Immunol. 2: 229-234.
21. Kersh, G. J., E. N. Kersh, D. H. Fremont, and P. M. Allen. 1998. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 9: 817-826.
22. McKeithan, T. W. 1995. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA 92: 5042-5046.
23. Rabinowitz, J. D., C. Beeson, C. Wulfing, K. Tate, P. M. Allen, M. M. Davis, and H. M. McConnell. 1996. Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity 5: 125-135.
24. Van der Merwe, P. A., and S. J. Davis. 2003. Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 21: 659-684.
25. Krogsgaard, M., N. Prado, E. J. Adams, X. L. He, D. C. Chow, D. B. Wilson, K. C. Garcia, and M. M. Davis. 2003. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol. Cell 12: 1367-1378. (Pubitemid 38037007)
26. Qi, S., M. Krogsgaard, M. M. Davis, and A. K. Chakraborty. 2006. Molecular flexibility can influence the stimulatory ability of receptor-ligand interactions at cell-cell junctions. Proc. Natl. Acad. Sci. USA 103: 4416-4421.
27. Delon, J., C. Gregoire, B. Malissen, S. Darche, F. Lemaitre, P. Kourilsky, J. P. Abastado, and A. Trautmann. 1998. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. Immunity 9: 467-473.
28. Cochran, J. R., T. O. Cameron, and L. J. Stern. 2000. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity 12: 241-250.
29. Minguet, S., M. Swamy, B. Alarcon, I. F. Luescher, and W. W. Schamel. 2007. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Immunity 26: 43-54. (Pubitemid 46109342)
30. Stone, J. D., J. R. Cochran, and L. J. Stern. 2001. T-cell activation by soluble MHC oligomers can be described by a two-parameter binding model. Biophys. J. 81: 2547-2557.
31. Stone, J. D., and L. J. Stern. 2006. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement. J. Immunol. 176: 1498-1505.
32. + T cells through transfer of the peptide to T cell MHC molecules. Proc. Natl. Acad. Sci. USA 99: 13729-13734.
33. Schott, E., N. Bertho, Q. Ge, M. M. Maurice, and H. L. Ploegh. 2002. Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules. Proc. Natl. Acad. Sci. USA 99: 13735-13740.
34. Holler, P. D., L. K. Chlewicki, and D. M. Kranz. 2003. TCRs with high affinity for foreign pMHC show self-reactivity. Nat. Immunol. 4: 55-62.
35. Holler, P. D., P. O. Holman, E. V. Shusta, S. O'Herrin, K. D. Wittrup, and D. M. Kranz. 2000. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc. Natl. Acad. Sci. USA 97: 5387-5392.
36. Jones, L. L., S. E. Brophy, A. J. Bankovich, L. A. Colf, N. A. Hanick, K. C. Garcia, and D. M. Kranz. 2006. Engineering and characterization of a stabilized α1/α2 module of the class I major histocompatibility complex product Ld. J. Biol. Chem. 281: 25734-25744.
37. Zhang, B., N. A. Bowerman, J. K. Salama, H. Schmidt, M. T. Spiotto, A. Schietinger, P. Yu, Y. X. Fu, R. R. Weichselbaum, D. A. Rowley, et al. 2007. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J. Exp. Med. 204: 49-55.
38. Daniels, M. A., E. Teixeiro, J. Gill, B. Hausmann, D. Roubaty, K. Holmberg, G. Werlen, G. A. Hollander, N. R. J. Gascoigne, and E. Palmer. 2006. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 444: 724-729.
39. Rosette, C., G. Werlen, M. A. Daniels, P. O. Holman, S. M. Alam, P. J. Travers, N. R. Gascoigne, E. Palmer, and S. C. Jameson. 2001. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 15: 59-70.
40. Savage, P. A., J. J. Boniface, and M. M. Davis. 1999. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10: 485-492.
41. Lee, P. U., H. R. Churchill, M. Daniels, S. C. Jameson, and D. M. Kranz. 2000. Role of 2CT cell receptor residues in the binding of self- and allo-major histocompatibility complexes. J. Exp. Med. 191: 1355-1364.
42. Manning, T. C., C. J. Schlueter, T. C. Brodnicki, E. A. Parke, J. A. Speir, K. C. Garcia, L. Teyton, I. A. Wilson, and D. M. Kranz. 1998. Alanine scanning mutagenesis of an αβT cell receptor: mapping the energy of antigen recognition. Immunity 8: 413-425.
43. Garcia, K. C., M. D. Tallquist, L. R. Pease, A. Brunmark, C. A. Scott, M. Degano, E. A. Stura, P. A. Peterson, I. A. Wilson, and L. Teyton. 1997. αβT cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. Proc. Natl. Acad. Sci. USA 94: 13838-13843.
44. Wu, L. C., D. S. Tuot, D. S. Lyons, K. C. Garcia, and M. M. Davis. 2002. Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature 418: 552-556.
45. Letourneur, F., and B. Malissen. 1989. Derivation of a T cell hybridoma variant deprived of functional T cell receptor α and β chain transcripts reveals a nonfunctional α-mRNA of BW5147 origin. Eur. J. Immunol. 19: 2269-2274.
46. Holland, G. P., and M. W. Steward. 1991. The influence of epitope density on the estimation of the affinity of antibody for complex antigens. J. Immunol. Methods 138: 245-255.
47. Hornick, C. L., and F. Karush. 1969. The interaction of hapten-coupled bacteriophage phi-X-174 with antihapten antibody. Isr. J. Med. Sci. 5: 163-170.
48. Werthen, M., and H. Nygren. 1988. Effect of antibody affinity on the isotherm of antibody binding to surface-immobilized antigen. J. Immunol. Methods 115: 71-78.
49. Werthen, M., and H. Nygren. 1993. Cooperativity in the antibody binding to surface-adsorbed antigen. Biochim. Biophys. Acta 1162: 326-332.
50. Alam, S. M., G. M. Davies, C. M. Lin, T. Zal, W. Nasholds, S. C. Jameson, K. A. Hogquist, N. R. Gascoigne, and P. J. Travers. 1999. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity 10: 227-237.
51. Cheroutre, H., and F. Lambolez. 2008. Doubting the TCR coreceptor function of CD8αα. Immunity 28: 149-159.
52. Feinerman, O., J. Veiga, J. R. Dorfman, R. N. Germain, and G. Altan-Bonnet. 2008. Variability and robustness in T cell activation from regulated heterogeneity in protein levels. Science 321: 1081-1084.
53. Sykulev, Y., A. Brunmark, T. J. Tsomides, S. Kageyama, M. Jackson, P. A. Peterson, and H. N. Eisen. 1994. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA 91: 11487-11491.
54. Jones, L. L., L. A. Colf, J. D. Stone, K. C. Garcia, and D. M. Kranz. 2008. Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientation. J. Immunol. 181: 6255-6264.
55. Altan-Bonnet, G., and R. N. Germain. 2005. Modeling T cell antigen discrimination based on feedback control of digital ERK responses. PLoS Biol. 3: e356.
56. Stefanova, I., B. Hemmer, M. Vergelli, R. Martin, W. E. Biddison, and R. N. Germain. 2003. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol. 4: 248-254.
57. + T cell clones. Adv. Immunol. 96: 103-139.
58. + T cells. J. Exp. Med. 186: 757-766.
59. Malherbe, L., C. Hausl, L. Teyton, and M. G. McHeyzer-Williams. 2004. Clonal selection of helper T cells is determined by an affinity threshold with no further skewing of TCR binding properties. Immunity 21: 669-679.
60. Malherbe, L., L. Mark, N. Fazilleau, L. J. McHeyzer-Williams, and M. G. McHeyzer-Williams. 2008. Vaccine adjuvants alter TCR-based selection thresholds. Immunity 28: 698-709.
61. Krogsgaard, M., and M. M. Davis. 2005. How T cells 'see' antigen. Nat. Immunol. 6: 239-245.
62. Motyka, B., and H. S. Teh. 1998. Naturally occurring low affinity peptide/MHC class I ligands can mediate negative selection and T cell activation. J. Immunol. 160: 77-86. (Pubitemid 28116717)
63. Dutoit, V., P. Guillaume, M. Ayyoub, C. S. Hesdorffer, I. F. Luescher, and D. Valmori. 2003. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate. J. Immunol. 170: 5110-5117.
64. Segura, J. M., P. Guillaume, S. Mark, D. Dojcinovic, A. Johannsen, G. Bosshard, G. Angelov, D. F. Legler, H. Vogel, and I. F. Luescher. 2008. Increased mobility of MHC I-peptide complexes decreases the sensitivity of antigen recognition. J. Biol. Chem. 283: 24254-24263.
65. Ma, Z., K. A. Sharp, P. A. Janmey, and T. H. Finkel. 2008. Surface-anchored monomeric agonist pMHCs alone trigger TCR with high sensitivity. PLoS Biol. 6: e43.
66. Brophy, S. E., L. L. Jones, P. D. Holler, and D. M. Kranz. 2007. Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity. Mol. Immunol. 44: 2184-2194.
67. McCluskey, J., L. F. Boyd, P. F. Highet, J. Inman, and D. H. Margulies. 1988. T cell activation by purified, soluble, class I MHC molecules: requirement for polyvalency. J. Immunol. 141: 1451-1455.
68. Boniface, J. J., J. D. Rabinowitz, C. Wulfing, J. Hampl, Z. Reich, J. D. Altman, R. M. Kantor, C. Beeson, H. M. McConnell, and M. M. Davis. 1998. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. Immunity 9: 459-466.
69. Yachi, P. P., J. Ampudia, N. R. Gascoigne, and T. Zal. 2005. Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse. Nat. Immunol. 6: 785-792.
70. Dustin, M. L. 2008. T-cell activation through immunological synapses and kinapses. Immunol. Rev. 221: 77-89.
71. Cohen, C. J., Z. Zheng, R. Bray, Y. Zhao, L. A. Sherman, S. A. Rosenberg, and R. A. Morgan. 2005. Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR. J. Immunol. 175: 5799-5808.
72. Engels, B., E. Noessner, B. Frankenberger, T. Blankenstein, D. J. Schendel, and W. Uckert. 2005. Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes. Hum. Gene Ther. 16: 799-810.
73. Johnson, L. A., B. Heemskerk, D. J. Powell, Jr., C. J. Cohen, R. A. Morgan, M. E. Dudley, P. F. Robbins, and S. A. Rosenberg. 2006. Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes. J. Immunol. 177: 6548-6559.
74. + T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity 22: 117-129.
75. Morgan, R. A., M. E. Dudley, J. R. Wunderlich, M. S. Hughes, J. C. Yang, R. M. Sherry, R. E. Royal, S. L. Topalian, U. S. Kammula, N. P. Restifo, et al. 2006. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314: 126-129.